Trade AstraZeneca ^AZN

Killip class at presentation and immediate versus staged multivessel PCI in patients with STEMI

AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value

Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

New Drugs Are Replacing Chemo for Aggressive Breast Cancer | Hindustan Times

Astrazeneca Plc $AZN Shares Sold by Ritholtz Wealth Management - Zolmax

3 UK Stocks That May Be Trading At Up To 40% Below Intrinsic Value Estimates

CENTRAL TRUST Co Takes Position in AstraZeneca PLC $AZNCF - Stock Observer

Ritholtz Wealth Management Lowers Stake in Astrazeneca Plc $AZN - Daily Political

Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin

Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial

Can AstraZeneca PLC (AZN) Grow Its Rare Disease Portfolio Through Ultomiris Expansion?

Nations Financial Group Inc. IA ADV Acquires New Shares in AstraZeneca PLC $AZNCF - Stock Observer

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study

Redditors Think Tempus AI (TEM) Still Has 10X Potential

Balancing openness and control: Cross-border health data and AI governance in China

Vaughan Nelson Investment Management L.P. Purchases Shares of 10,355 AstraZeneca PLC $AZNCF - Stock Observer

Robbins Farley Invests $4.96 Million in AstraZeneca PLC $AZNCF - Daily Political

AstraZeneca announces major financial investment to bring medical breakthroughs to patients' bedsides - Yahoo News Canada

3 UK Stocks Trading Below Fair Value On Cash Flow Views

5 Best Weight Loss Drug Stocks to Buy in 2026

Biotech Stocks Facing FDA Decision In July 2026

6,851 Shares in AstraZeneca PLC $AZNCF Acquired by Town & Country Bank & Trust CO dba First Bankers Trust CO - Stock Observer

Autologous stem cell transplantation for AL amyloidosis: a multicenter summary of outcomes 2010-2020

Purpose Unlimited Inc. Takes Position in Astrazeneca Plc $AZN - Zolmax

The top 3 FTSE shares for beginner investors to consider buying in 2026

3 UK Stocks Trading Below Cash Flow Value

Astrazeneca Plc $AZN is Mengis Capital Management Inc.'s 5th Largest Position - Zolmax

Rockefeller Capital Management L.P. Sells 147,931 Shares of Astrazeneca Plc $AZN - Stock Observer

S Harris Financial Group LLC Acquires Shares of 7,355 Astrazeneca Plc $AZN - Daily Political

3 UK AI Healthcare Stocks With Revenue Growth And Funding Risk

4,532 Shares in Astrazeneca Plc $AZN Acquired by Keenan LLC - Daily Political

Larry Mathis Financial Planning LLC Purchases Shares of 5,770 Astrazeneca Plc $AZN - Daily Political

AstraZeneca (LSE:AZN) Stock Could Be 20.2% Below Fair Value After Recent Pullback

India could be on the radar for AstraZeneca's oral GLP-1 drug: MD

Deutsche Bank Remains a Hold on Novo Nordisk (0QIU)

Compound Planning Inc. Purchases 9,655 Shares of Astrazeneca Plc $AZN

Astrazeneca (AZN) Stock Drops Despite Market Gains: Important Facts to Note

Castle Hook Partners LP Buys New Holdings in Astrazeneca Plc $AZN

AZN: New Approvals And AI Use Will Support Future Repricing

AstraZeneca (AZN) Advances Oral GLP-1 Receptor Agonist Elecoglipron to Phase III Trials

Fred Alger Management LLC Buys 1,263,721 Shares of Astrazeneca Plc $AZN - Markets Daily

Astrazeneca Plc $AZN Shares Acquired by National Bank of Canada FI - Stock Observer

Crawford Investment Counsel Inc. Decreases Position in Astrazeneca Plc $AZN - Stock Observer

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial

Exploiting androgen receptor agonism as a treatment strategy in estrogen receptor-positive metastatic breast cancer

Oddo BHF Asset Management Sas Invests $35.06 Million in Astrazeneca Plc $AZN - Daily Political

Astrazeneca Plc (NYSE:AZN) Receives $205.33 Average Price Target from Brokerages - Daily Political

Healthcare of Ontario Pension Plan Trust Fund Acquires 9,897 Shares of Astrazeneca Plc $AZN - Daily Political

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors

AstraZeneca (AZN) Faces Changes in Medicare Drug Price Negotiation Framework

Global Pharmaceutical Companies Boost US Manufacturing Amid Tariff Threats, ETPharma

AstraZeneca (AZN) Receives Priority Review for Ultomiris Treatment Application

Seven Mile Advisory Invests $738,000 in AstraZeneca PLC $AZNCF - Markets Daily

Mosaic Financial Group LLC Makes New Investment in AstraZeneca PLC $AZNCF

Mosaic Financial Group LLC Takes $913,000 Position in AstraZeneca PLC $AZNCF - Zolmax

AbCellera Biologics (ABCL) Stock Valuation After Adding Drug Development Expert Victor Sandor To The Board

Patterns of medication use across society from national primary care dispensing data

Single-cell RNA sequencing of terminal ileal biopsies identifies signatures of Crohn's disease pathogenesis

Citi Initiates a Buy Rating on AstraZeneca (AZN)

Icon Wealth Advisors LLC Makes New $2.47 Million Investment in AstraZeneca PLC $AZNCF - Zolmax

FDA TRUQAP Approval Highlights AstraZeneca's Precision Oncology And Valuation Gap

Astrazeneca Plc $AZN is Foresight Global Investors Inc.'s Largest Position

Livet Wealth LLC Invests $651,000 in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca : FDA Approves Truqap Combination For PTEN-Deficient Metastatic Prostate Cancer

Astrazeneca Plc $AZN is Trillium Asset Management LLC's 5th Largest Position - Daily Political

TRUQAP® (capivasertib) combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer | Morningstar

AstraZeneca (AZN) Receives FDA Approval for Truqap in Advanced Prostate Cancer

AstraZeneca's Drug Combination for Prostate Cancer Treatment Gets U.S. Approval | Morningstar

AstraZeneca (AZN) Secures U.S. Approval for Innovative Prostate Cancer Treatment

Roche reports FDA approval for prostate cancer companion diagnostic

Is AbCellera (ABCL) Using Boardroom Oncology Talent to Redefine Its Clinical Ambitions?

Truqap approved for PTEN-deficient metastatic hormone-sensitive prostate cancer

Vaughan David Investments LLC IL Invests $88.37 Million in AstraZeneca PLC $AZNCF - Markets Daily

If AI Healthcare Rewires Medicine These Three Stocks Could Lead

SmartHarvest Portfolios LLC Takes $751,000 Position in Astrazeneca Plc $AZN - Markets Daily

Woodley Farra Manion Portfolio Management Inc. Lowers Holdings in Astrazeneca Plc $AZN - Daily Political

Real-world cell-free circulating tumor DNA (ctDNA) analysis identifies CDK4/6 inhibitor resistance and tumor evolution in HR+ advanced breast cancer

7,854 Shares in Astrazeneca Plc $AZN Bought by Hamel Associates Inc. - Markets Daily

Dorsey & Whitney Trust CO LLC Has $3.94 Million Stake in Astrazeneca Plc $AZN - Stock Observer

AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancer - The Economic Times

Type 2 Diabetes breakthrough: No more a jab - AstraZeneca's new oral GLP-1 delivers up to 10.5% weight loss

Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

Opinion - Big Pharma lost in court - Congress must not bail it out

Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon

Jim Cramer on AstraZeneca: "On Track to Hit the Ambitious Long-Term Financial Targets"

WINTON GROUP Ltd Invests $965,000 in Astrazeneca Plc $AZN - Daily Political

Is It Too Late To Reassess AstraZeneca (LSE:AZN) After Its Strong Multi‑Year Run?

"Brexit into Asia": British Capital's Shift Towards China

Encouraging trial results for AstraZeneca's new weight-loss pill - Japan Today

Astrazeneca (NYSE:AZN) Given "Buy" Rating at Jefferies Financial Group - Markets Daily

ADA: AZ's oral GLP-1 shows 'competitive efficacy' in phase 2

Jefferies Financial Group Reaffirms "Buy" Rating for AstraZeneca (LON:AZN) - Markets Daily

Deutsche Bank Aktiengesellschaft Reiterates "Sell" Rating for Astrazeneca (NYSE:AZN) - Stock Observer

GSK (GSK) Stock Slides 3% Following $10.6B Nuvalent Acquisition Deal

AstraZeneca's New Oral GLP-1 Aids Weight Loss and Lowers Blood Sugar - AOL

6,250 Shares in AstraZeneca PLC $AZNCF Acquired by Monetary Management Group Inc. - Daily Political

AstraZeneca's Elecoglipron Pill: Shattering Weight Loss Records with 10.5% Reduction, ETPharma

Week Ahead: US job data takes the spotlight

USD/CHF Price Forecast: Evaluating the 2026 Breakout Amid Fed and SNB Policy Divergence

SK Hynix Equity Analysis 2026: The Intersection of AI Memory Dominance and Valuation Arbitrage

Gold Price Forecast: XAU/USD Plunges to 2026 Lows Amid Hawkish Fed and Strong Dollar

USD/JPY Forecast: Analyzing the 161.60 Threshold Amid BoJ Policy Friction and Intervention Risks

FOMC June 2026: Warsh’s Hawkish Pivot and Forex Market Impact

Japan and South Korea Stocks Rebound as Nikkei Hits Fresh High and KOSPI Rises Over 1.5%

5 Ways South African Traders Can Capitalise on the SpaceX Listing Aftermath

How to Trade the SpaceX (SPCX) IPO Surge From South Africa With CFDs — Without Owning a Single Share

SpaceX IPO Puts S&P 500 Inclusion Question in Focus

Apple Stock Falls 6.12% as Mac and iPad Price Hikes Raise Demand Concerns

Micron Earnings Fuel AI Memory Rally as Supply Tightness Supports Memory Chip Outlook

OpenAI IPO Could Be Delayed as SpaceX Volatility Tests AI Listings

Bitcoin Price Falls Below $59,000 as Hot PCE Data Revives Fed Rate-Hike Fears

Gold Price Today, June 26: Spot Gold Reclaims $4,000 Following Inline US PCE Inflation Data

Micron Projects Multi-Year Memory Shortage Following Blowout Q3 Earnings

SK Hynix Stock Surges on $29.4bn Nasdaq ADR Plan as AI Memory Demand Drives Relating Hopes

US Dollar Tracks Toward Largest Monthly Gain in a Year Amid Resilient Economic Data